Correlation of tau gene polymorphism with age at onset of Parkinson's disease

Neuroscience Letters

Volumn 405, Issue 3, 2006, Pages 202-206

  Kobayashi, Hideaki ^a   Ujike, Hiroshi ^b   Hasegawa, Junko ^c   Yamamoto, Mitsutoshi ^d   Kanzaki, Akihiro ^e   Sora, Ichiro ^a,c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

Case control study; Japanese; MAPT; Parkinson's disease; Polymorphism

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC SIMILARITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAU PROTEINS;

EID: 33746899013     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.06.057     Document Type: Article

References (33)

1. Arima K., Hirai S., Sunohara N., Aoto K., Izumiyama Y., Ueda K., Ikeda K., and Kawai M. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Brain Res. 843 (1999) 53-61
2. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., and Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8 (1999) 711-715
3. Clark L.N., Levy G., Tang M.X., Mejia-Santana H., Ciappa A., Tycko B., Cote L.J., Louis E.D., Mayeux R., and Marder K. The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neurosci. Lett. 347 (2003) 17-20
4. Conrad C., Amano N., Andreadis A., Xia Y., Namekataf K., Oyama F., Ikeda K., Wakabayashi K., Takahashi H., Thal L.J., Katzman R., Shackelford D.A., Matsushita M., Masliah E., and Sawa A. Differences in a di-nucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci. Lett. 250 (1998) 135-137
5. de Silva R., Hardy J., Crook J., Khan N., Graham E.A., Morris C.M., Wood N.W., and Lees A.J. The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease. Neurosci. Lett. 330 (2002) 201-203
6. de Silva R., Weiler M., Morris H.R., Martin E.R., Wood N.W., and Lees A.J. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci. Lett. 311 (2001) 145-148
7. Diederich N.J., Moore C.G., Leurgans S.E., Chmura T.A., and Goetz C.G. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch. Neurol. 60 (2003) 529-533
8. Ezquerra M., Pastor P., Valldeoriola F., Molinuevo J.L., Blesa R., Tolosa E., and Oliva R. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci. Lett. 275 (1999) 183-186
9. Farrer M., Skipper L., Berg M., Bisceglio G., Hanson M., Hardy J., Adam A., Gwinn-Hardy K., and Aasly J. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci. Lett. 322 (2002) 83-86
10. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 56 (1999) 33-39
11. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T., Trojanowski J.Q., and Lee V.M. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300 (2003) 636-640
12. Golbe L.I., Lazzarini A.M., Spychala J.R., Johnson W.G., Stenroos E.S., Mark M.H., and Sage J.I. The tau A0 allele in Parkinson's disease. Mov. Disord. 16 (2001) 442-447
13. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., and Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
14. Ishizawa T., Mattila P., Davies P., Wang D., and Dickson D.W. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J. Neuropathol. Exp. Neurol. 62 (2003) 389-397
15. Kubis N., Faucheux B.A., Ransmayr G., Damier P., Duyckaerts C., Henin D., Forette B., Le Charpentier Y., Hauw J.J., Agid Y., and Hirsch E.C. Preservation of midbrain catecholaminergic neurons in very old human subjects. Brain 123 Pt 2 (2000) 366-373
16. Kwok J.B., Teber E.T., Loy C., Hallupp M., Nicholson G., Mellick G.D., Buchanan D.D., Silburn P.A., and Schofield P.R. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann. Neurol. 55 (2004) 329-334
17. Levecque C., Elbaz A., Clavel J., Vidal J.S., Amouyel P., Alperovitch A., Tzourio C., and Chartier-Harlin M.C. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 478-480
18. Maraganore D.M., Hernandez D.G., Singleton A.B., Farrer M.J., McDonnell S.K., Hutton M.L., Hardy J.A., and Rocca W.A. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann. Neurol. 50 (2001) 658-661
19. Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen Jr. F.H., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Ribble R.C., Booze M.W., Rogala A., Hauser M.A., Zhang F., Gibson R.A., Middleton L.T., Roses A.D., Haines J.L., Scott B.L., Pericak-Vance M.A., and Vance J.M. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 286 (2001) 2245-2250
20. Marttila R.J., and Rinne U.K. Epidemiology of Parkinson's disease in Finland. Acta Neurol. Scand. 53 (1976) 81-102
21. Morris H.R., Janssen J.C., Bandmann O., Daniel S.E., Rossor M.N., Lees A.J., and Wood N.W. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 66 (1999) 665-667
22. Oliveira S.A., Scott W.K., Zhang F., Stajich J.M., Fujiwara K., Hauser M., Scott B.L., Pericak-Vance M.A., Vance J.M., and Martin E.R. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype. Neurogenetics 5 (2004) 147-155
23. Pastor P., Ezquerra M., Munoz E., Marti M.J., Blesa R., Tolosa E., and Oliva R. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann. Neurol. 47 (2000) 242-245
24. Peplonska B., Zekanowski C., Religa D., Czyzewski K., Styczynska M., Pfeffer A., Gabryelewicz T., Golebiowski M., Luczywek E., Wasiak B., Barczak A., Chodakowska M., Barcikowska M., and Kuznicki J. Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci. Lett. 348 (2003) 163-166
25. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825
26. Schneider S., Roessli D., and Excoffier L. Arlequin: A Software for Population Genetics Data Analysis. Ver 2.000 (2000), Genetics and Biometry Lab, Department of Anthropology, University of Geneva
27. Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen Jr. F.H., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Slotterbeck B., Booze M.W., Ribble R.C., Rampersaud E., West S.G., Gibson R.A., Middleton L.T., Roses A.D., Haines J.L., Scott B.L., Vance J.M., and Pericak-Vance M.A. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286 (2001) 2239-2244
28. Skipper L., Wilkes K., Toft M., Baker M., Lincoln S., Hulihan M., Ross O.A., Hutton M., Aasly J., and Farrer M. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am. J. Hum. Genet. 75 (2004) 669-677
29. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6469-6473
30. Spillantini M.G., and Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21 (1998) 428-433
31. Ujike H., Yamamoto M., Kanzaki A., Okumura K., Takaki M., and Kuroda S. Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease. Mov. Disord. 16 (2001) 111-113
32. Zappia M., Annesi G., Nicoletti G., Serra P., Arabia G., Pugliese P., Messina D., Caracciolo M., Romeo N., Annesi F., Pasqua A.A., Spadafora P., Civitelli D., Romeo N., Epifanio A., Morgante L., and Quattrone A. Association of tau gene polymorphism with Parkinson's disease. Neurol. Sci. 24 (2003) 223-224
33. Zhang J., Song Y., Chen H., and Fan D. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease. Eur. Neurol. 53 (2005) 15-21